Sorafenib for Advanced and Refractory Desmoid Tumors
- Citation:
- N Engl J Med vol 379 (25) 2417-28
- Year:
- 2018
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 8
- Parents:
- 2884
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Health Outcomes
- Pharmas:
- Bayer
- Grants:
- U10CA180821, U10CA180882, U24CA196171, U10CA180833, U10CA180838, U10CA180857, U10CA180858, UG1CA189850, UG1CA189957, U10CA180820, U10CA180868, U10CA180888, U10CA180826, P30 CA008748
- Corr. Author:
- Authors:
- Mrinal M. Gounder Michelle R. Mahoney Brian A. Van Tine Vinod Ravi Steven Attia Hari A. Deshpande Abha A. Gupta Mohammed M. Milhem Robert M. Conry Sujana Movva Michael J. Pishvaian Richard F. Riedel Tarek Sabagh William D. Tap Natally Horvat Ethan Basch Lawrence H. Schwartz Robert G. Maki Narasimhan P. Agaram Robert A. Lefkowitz Yousef Mazaheri Rikiya Yamashita John J. Wright Amylou C. Dueck Gary K. Schwartz
- Networks:
- COLUMBIA, IA018, LAPS-CT018, LAPS-MD017, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-NC010, LAPS-NY016, LAPS-TX035, OH084
- Study
- Alliance-A091105
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: